4elk - Revision history

OCA at 15:04, 14 March 2024

OCA — Thu, 14 Mar 2024 15:04:29 GMT

←Older revision		Revision as of 15:04, 14 March 2024
Line 4:		Line 4:
	== Structural highlights ==		== Structural highlights ==
	<table><tr><td colspan='2'>[[4elk]] is a 4 chain structure with sequence from [https://en.wikipedia.org/wiki/Mus_musculus Mus musculus]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=4ELK OCA]. For a <b>guided tour on the structure components</b> use [https://proteopedia.org/fgij/fg.htm?mol=4ELK FirstGlance]. <br>		<table><tr><td colspan='2'>[[4elk]] is a 4 chain structure with sequence from [https://en.wikipedia.org/wiki/Mus_musculus Mus musculus]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=4ELK OCA]. For a <b>guided tour on the structure components</b> use [https://proteopedia.org/fgij/fg.htm?mol=4ELK FirstGlance]. <br>
-	</td></tr><tr id='ligand'><td class="sblockLbl"><b>[[Ligand\|Ligands:]]</b></td><td class="sblockDat" id="ligandDat"><scene name='pdbligand=ACT:ACETATE+ION'>ACT</scene>, <scene name='pdbligand=FMT:FORMIC+ACID'>FMT</scene>, <scene name='pdbligand=MLI:MALONATE+ION'>MLI</scene></td></tr>	+	</td></tr><tr id='method'><td class="sblockLbl"><b>[[Empirical_models\|Method:]]</b></td><td class="sblockDat" id="methodDat">X-ray diffraction, [[Resolution\|Resolution]] 2.1Å</td></tr>
		+	<tr id='ligand'><td class="sblockLbl"><b>[[Ligand\|Ligands:]]</b></td><td class="sblockDat" id="ligandDat"><scene name='pdbligand=ACT:ACETATE+ION'>ACT</scene>, <scene name='pdbligand=FMT:FORMIC+ACID'>FMT</scene>, <scene name='pdbligand=MLI:MALONATE+ION'>MLI</scene></td></tr>
	<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[https://proteopedia.org/fgij/fg.htm?mol=4elk FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=4elk OCA], [https://pdbe.org/4elk PDBe], [https://www.rcsb.org/pdb/explore.do?structureId=4elk RCSB], [https://www.ebi.ac.uk/pdbsum/4elk PDBsum], [https://prosat.h-its.org/prosat/prosatexe?pdbcode=4elk ProSAT]</span></td></tr>		<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[https://proteopedia.org/fgij/fg.htm?mol=4elk FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=4elk OCA], [https://pdbe.org/4elk PDBe], [https://www.rcsb.org/pdb/explore.do?structureId=4elk RCSB], [https://www.ebi.ac.uk/pdbsum/4elk PDBsum], [https://prosat.h-its.org/prosat/prosatexe?pdbcode=4elk ProSAT]</span></td></tr>
	</table>		</table>
-	<div style="background-color:#fffaf0;">
-	== Publication Abstract from PubMed ==
-	Glycolipids presented by the major histocompatibility complex (MHC) class I homolog CD1d are recognized by natural killer T cells (NKT cells) characterized by either a semi-invariant T cell antigen receptor (TCR) repertoire (type I NKT cells or iNKT cells) or a relatively variable TCR repertoire (type II NKT cells). Here we describe the structure of a type II NKT cell TCR in complex with CD1d-lysosulfatide. Both TCR alpha-chains and TCR beta-chains made contact with the CD1d molecule with a diagonal footprint, typical of MHC-TCR interactions, whereas the antigen was recognized exclusively with a single TCR chain, similar to the iNKT cell TCR. Type II NKT cell TCRs, therefore, recognize CD1d-sulfatide complexes by a distinct recognition mechanism characterized by the TCR-binding features of both iNKT cells and conventional peptide-reactive T cells.
-
-	Type II natural killer T cells use features of both innate-like and conventional T cells to recognize sulfatide self antigens.,Girardi E, Maricic I, Wang J, Mac TT, Iyer P, Kumar V, Zajonc DM Nat Immunol. 2012 Sep;13(9):851-6. doi: 10.1038/ni.2371. Epub 2012 Jul 22. PMID:22820602<ref>PMID:22820602</ref>
-
-	From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.<br>
-	</div>
-	<div class="pdbe-citations 4elk" style="background-color:#fffaf0;"></div>
-	== References ==
-	<references/>
	__TOC__		__TOC__
	</StructureSection>		</StructureSection>

OCA at 07:17, 28 September 2022

OCA — Wed, 28 Sep 2022 07:17:02 GMT

←Older revision		Revision as of 07:17, 28 September 2022
Line 1:		Line 1:

	==Crystal structure of the Hy19.3 type II NKT TCR==		==Crystal structure of the Hy19.3 type II NKT TCR==
-	<StructureSection load='4elk' size='340' side='right' caption='[[4elk]], [[Resolution\|resolution]] 2.10Å' scene=''>	+	<StructureSection load='4elk' size='340' side='right'caption='[[4elk]], [[Resolution\|resolution]] 2.10Å' scene=''>
	== Structural highlights ==		== Structural highlights ==
-	<table><tr><td colspan='2'>[[4elk]] is a 4 chain structure with sequence from [~~http~~://en.wikipedia.org/wiki/~~Lk3_transgenic_mice Lk3 transgenic mice~~]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=4ELK OCA]. For a <b>guided tour on the structure components</b> use [~~http~~://~~oca~~.~~weizmann.ac.il/oca-docs~~/fgij/fg.htm?mol=4ELK FirstGlance]. <br>	+	<table><tr><td colspan='2'>[[4elk]] is a 4 chain structure with sequence from [https://en.wikipedia.org/wiki/Mus_musculus Mus musculus]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=4ELK OCA]. For a <b>guided tour on the structure components</b> use [https://proteopedia.org/fgij/fg.htm?mol=4ELK FirstGlance]. <br>
-	</td></tr><tr id='ligand'><td class="sblockLbl"><b>[[Ligand\|Ligands:]]</b></td><td class="sblockDat"><scene name='pdbligand=ACT:ACETATE+ION'>ACT</scene>, <scene name='pdbligand=FMT:FORMIC+ACID'>FMT</scene>, <scene name='pdbligand=MLI:MALONATE+ION'>MLI</scene>~~</td></tr>~~	+	</td></tr><tr id='ligand'><td class="sblockLbl"><b>[[Ligand\|Ligands:]]</b></td><td class="sblockDat" id="ligandDat"><scene name='pdbligand=ACT:ACETATE+ION'>ACT</scene>, <scene name='pdbligand=FMT:FORMIC+ACID'>FMT</scene>, <scene name='pdbligand=MLI:MALONATE+ION'>MLI</scene></td></tr>
-	~~<tr id='related'><td class="sblockLbl"><b>[[Related_structure\|Related:]]</b></td><td class="sblockDat">[[4elm\|4elm]]</td></tr>~~	+	<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[https://proteopedia.org/fgij/fg.htm?mol=4elk FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=4elk OCA], [https://pdbe.org/4elk PDBe], [https://www.rcsb.org/pdb/explore.do?structureId=4elk RCSB], [https://www.ebi.ac.uk/pdbsum/4elk PDBsum], [https://prosat.h-its.org/prosat/prosatexe?pdbcode=4elk ProSAT]</span></td></tr>
-	<tr id='gene'><td class="sblockLbl"><b>[[Gene\|Gene:]]</b></td><td class="sblockDat">Valpha1 (mouse variable domain, human constant domain) ([http://www.ncbi.nlm.nih.gov/Taxonomy/Browser/wwwtax.cgi?mode=Info&srchmode=5&id=10090 LK3 transgenic mice]), Vbeta16 (mouse variable domain, human constant domain) ([http://www.ncbi.nlm.nih.gov/Taxonomy/Browser/wwwtax.cgi?mode=Info&srchmode=5&id=10090 LK3 transgenic mice])</td></tr>	+
-	<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[~~http~~://~~oca~~.~~weizmann.ac.il/oca-docs~~/fgij/fg.htm?mol=4elk FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=4elk OCA], [~~http~~://pdbe.org/4elk PDBe], [~~http~~://www.rcsb.org/pdb/explore.do?structureId=4elk RCSB], [~~http~~://www.ebi.ac.uk/pdbsum/4elk PDBsum], [~~http~~://prosat.h-its.org/prosat/prosatexe?pdbcode=4elk ProSAT]</span></td></tr>	+
	</table>		</table>
	<div style="background-color:#fffaf0;">		<div style="background-color:#fffaf0;">
Line 22:		Line 20:
	__TOC__		__TOC__
	</StructureSection>		</StructureSection>
-	[[Category: ~~Lk3 transgenic mice~~]]	+	[[Category: Large Structures]]
-	[[Category: Girardi, E]]	+	[[Category: Mus musculus]]
-	[[Category: Iyer, P]]	+	[[Category: Girardi E]]
-	[[Category: Kumar, V]]	+	[[Category: Iyer P]]
-	[[Category: Mac~~, T T~~]]	+	[[Category: Kumar V]]
-	[[Category: Maricic, I]]	+	[[Category: Mac TT]]
-	[[Category: Wang, J]]	+	[[Category: Maricic I]]
-	[[Category: Zajonc~~, D M]]~~	+	[[Category: Wang J]]
-	~~[[Category: Antigen presentation]]~~	+	[[Category: Zajonc DM]]
-	~~[[Category: Immune system]]~~	+
-	~~[[Category: Type ii nkt cell~~]]	+

OCA at 02:50, 11 December 2016

OCA — Sun, 11 Dec 2016 02:50:14 GMT

←Older revision		Revision as of 02:50, 11 December 2016
Line 1:		Line 1:
		+
	==Crystal structure of the Hy19.3 type II NKT TCR==		==Crystal structure of the Hy19.3 type II NKT TCR==
	<StructureSection load='4elk' size='340' side='right' caption='[[4elk]], [[Resolution\|resolution]] 2.10Å' scene=''>		<StructureSection load='4elk' size='340' side='right' caption='[[4elk]], [[Resolution\|resolution]] 2.10Å' scene=''>
	== Structural highlights ==		== Structural highlights ==
-	<table><tr><td colspan='2'>[[4elk]] is a 4 chain structure with sequence from [http://en.wikipedia.org/wiki/~~Mus_musculus Mus musculus~~]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=4ELK OCA]. For a <b>guided tour on the structure components</b> use [http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=4ELK FirstGlance]. <br>	+	<table><tr><td colspan='2'>[[4elk]] is a 4 chain structure with sequence from [http://en.wikipedia.org/wiki/Lk3_transgenic_mice Lk3 transgenic mice]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=4ELK OCA]. For a <b>guided tour on the structure components</b> use [http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=4ELK FirstGlance]. <br>
	</td></tr><tr id='ligand'><td class="sblockLbl"><b>[[Ligand\|Ligands:]]</b></td><td class="sblockDat"><scene name='pdbligand=ACT:ACETATE+ION'>ACT</scene>, <scene name='pdbligand=FMT:FORMIC+ACID'>FMT</scene>, <scene name='pdbligand=MLI:MALONATE+ION'>MLI</scene></td></tr>		</td></tr><tr id='ligand'><td class="sblockLbl"><b>[[Ligand\|Ligands:]]</b></td><td class="sblockDat"><scene name='pdbligand=ACT:ACETATE+ION'>ACT</scene>, <scene name='pdbligand=FMT:FORMIC+ACID'>FMT</scene>, <scene name='pdbligand=MLI:MALONATE+ION'>MLI</scene></td></tr>
	<tr id='related'><td class="sblockLbl"><b>[[Related_structure\|Related:]]</b></td><td class="sblockDat">[[4elm\|4elm]]</td></tr>		<tr id='related'><td class="sblockLbl"><b>[[Related_structure\|Related:]]</b></td><td class="sblockDat">[[4elm\|4elm]]</td></tr>
-	<tr id='gene'><td class="sblockLbl"><b>[[Gene\|Gene:]]</b></td><td class="sblockDat">Valpha1 (mouse variable domain, human constant domain) ([http://www.ncbi.nlm.nih.gov/Taxonomy/Browser/wwwtax.cgi?mode=Info&srchmode=5&id=10090 ~~Mus musculus~~]), Vbeta16 (mouse variable domain, human constant domain) ([http://www.ncbi.nlm.nih.gov/Taxonomy/Browser/wwwtax.cgi?mode=Info&srchmode=5&id=10090 ~~Mus musculus~~])</td></tr>	+	<tr id='gene'><td class="sblockLbl"><b>[[Gene\|Gene:]]</b></td><td class="sblockDat">Valpha1 (mouse variable domain, human constant domain) ([http://www.ncbi.nlm.nih.gov/Taxonomy/Browser/wwwtax.cgi?mode=Info&srchmode=5&id=10090 LK3 transgenic mice]), Vbeta16 (mouse variable domain, human constant domain) ([http://www.ncbi.nlm.nih.gov/Taxonomy/Browser/wwwtax.cgi?mode=Info&srchmode=5&id=10090 LK3 transgenic mice])</td></tr>
-	<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=4elk FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=4elk OCA], [http://www.rcsb.org/pdb/explore.do?structureId=4elk RCSB], [http://www.ebi.ac.uk/pdbsum/4elk PDBsum]</span></td></tr>	+	<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=4elk FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=4elk OCA], [http://pdbe.org/4elk PDBe], [http://www.rcsb.org/pdb/explore.do?structureId=4elk RCSB], [http://www.ebi.ac.uk/pdbsum/4elk PDBsum], [http://prosat.h-its.org/prosat/prosatexe?pdbcode=4elk ProSAT]</span></td></tr>
	</table>		</table>
	<div style="background-color:#fffaf0;">		<div style="background-color:#fffaf0;">
Line 16:		Line 17:
	From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.<br>		From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.<br>
	</div>		</div>
		+	<div class="pdbe-citations 4elk" style="background-color:#fffaf0;"></div>
	== References ==		== References ==
	<references/>		<references/>
	__TOC__		__TOC__
	</StructureSection>		</StructureSection>
-	[[Category: ~~Mus musculus~~]]	+	[[Category: Lk3 transgenic mice]]
	[[Category: Girardi, E]]		[[Category: Girardi, E]]
	[[Category: Iyer, P]]		[[Category: Iyer, P]]

OCA at 16:51, 9 December 2014

OCA — Tue, 09 Dec 2014 16:51:16 GMT

←Older revision		Revision as of 16:51, 9 December 2014
Line 1:		Line 1:
-	[[~~Image:~~4elk.~~png~~\|~~left~~\|~~200px~~]]	+	==Crystal structure of the Hy19.3 type II NKT TCR==
		+	<StructureSection load='4elk' size='340' side='right' caption='[[4elk]], [[Resolution\|resolution]] 2.10Å' scene=''>
		+	== Structural highlights ==
		+	<table><tr><td colspan='2'>[[4elk]] is a 4 chain structure with sequence from [http://en.wikipedia.org/wiki/Mus_musculus Mus musculus]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=4ELK OCA]. For a <b>guided tour on the structure components</b> use [http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=4ELK FirstGlance]. <br>
		+	</td></tr><tr id='ligand'><td class="sblockLbl"><b>[[Ligand\|Ligands:]]</b></td><td class="sblockDat"><scene name='pdbligand=ACT:ACETATE+ION'>ACT</scene>, <scene name='pdbligand=FMT:FORMIC+ACID'>FMT</scene>, <scene name='pdbligand=MLI:MALONATE+ION'>MLI</scene></td></tr>
		+	<tr id='related'><td class="sblockLbl"><b>[[Related_structure\|Related:]]</b></td><td class="sblockDat">[[4elm\|4elm]]</td></tr>
		+	<tr id='gene'><td class="sblockLbl"><b>[[Gene\|Gene:]]</b></td><td class="sblockDat">Valpha1 (mouse variable domain, human constant domain) ([http://www.ncbi.nlm.nih.gov/Taxonomy/Browser/wwwtax.cgi?mode=Info&srchmode=5&id=10090 Mus musculus]), Vbeta16 (mouse variable domain, human constant domain) ([http://www.ncbi.nlm.nih.gov/Taxonomy/Browser/wwwtax.cgi?mode=Info&srchmode=5&id=10090 Mus musculus])</td></tr>
		+	<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=4elk FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=4elk OCA], [http://www.rcsb.org/pdb/explore.do?structureId=4elk RCSB], [http://www.ebi.ac.uk/pdbsum/4elk PDBsum]</span></td></tr>
		+	</table>
		+	<div style="background-color:#fffaf0;">
		+	== Publication Abstract from PubMed ==
		+	Glycolipids presented by the major histocompatibility complex (MHC) class I homolog CD1d are recognized by natural killer T cells (NKT cells) characterized by either a semi-invariant T cell antigen receptor (TCR) repertoire (type I NKT cells or iNKT cells) or a relatively variable TCR repertoire (type II NKT cells). Here we describe the structure of a type II NKT cell TCR in complex with CD1d-lysosulfatide. Both TCR alpha-chains and TCR beta-chains made contact with the CD1d molecule with a diagonal footprint, typical of MHC-TCR interactions, whereas the antigen was recognized exclusively with a single TCR chain, similar to the iNKT cell TCR. Type II NKT cell TCRs, therefore, recognize CD1d-sulfatide complexes by a distinct recognition mechanism characterized by the TCR-binding features of both iNKT cells and conventional peptide-reactive T cells.

-	~~{{STRUCTURE_4elk\| PDB=4elk \| SCENE= }}~~	+	Type II natural killer T cells use features of both innate-like and conventional T cells to recognize sulfatide self antigens.,Girardi E, Maricic I, Wang J, Mac TT, Iyer P, Kumar V, Zajonc DM Nat Immunol. 2012 Sep;13(9):851-6. doi: 10.1038/ni.2371. Epub 2012 Jul 22. PMID:22820602<ref>PMID:22820602</ref>

-	~~===Crystal structure~~ of the ~~Hy19~~.~~3 type II NKT TCR===~~	+	From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.<br>
-		+	</div>
-	~~{{ABSTRACT_PUBMED_22820602}}~~	+	== References ==
-		+	<references/>
-	==~~About this Structure~~==	+	__TOC__
-	~~[[4elk]] is a 4 chain structure with sequence from [http:~~//~~en.wikipedia.org/wiki/Mus_musculus Mus musculus]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=4ELK OCA].~~	+	</StructureSection>
	[[Category: Mus musculus]]		[[Category: Mus musculus]]
-	[[Category: Girardi, E.]]	+	[[Category: Girardi, E]]
-	[[Category: Iyer, P.]]	+	[[Category: Iyer, P]]
-	[[Category: Kumar, V.]]	+	[[Category: Kumar, V]]
-	[[Category: Mac, T T.]]	+	[[Category: Mac, T T]]
-	[[Category: Maricic, I.]]	+	[[Category: Maricic, I]]
-	[[Category: Wang, J.]]	+	[[Category: Wang, J]]
-	[[Category: Zajonc, D M.]]	+	[[Category: Zajonc, D M]]
	[[Category: Antigen presentation]]		[[Category: Antigen presentation]]
	[[Category: Immune system]]		[[Category: Immune system]]
	[[Category: Type ii nkt cell]]		[[Category: Type ii nkt cell]]

OCA at 08:11, 9 January 2013

OCA — Wed, 09 Jan 2013 08:11:32 GMT

←Older revision		Revision as of 08:11, 9 January 2013
Line 1:		Line 1:
-	[[Image:4elk.~~jpg~~\|left\|200px]]	+	[[Image:4elk.png\|left\|200px]]

	{{STRUCTURE_4elk\| PDB=4elk \| SCENE= }}		{{STRUCTURE_4elk\| PDB=4elk \| SCENE= }}
Line 5:		Line 5:
	===Crystal structure of the Hy19.3 type II NKT TCR===		===Crystal structure of the Hy19.3 type II NKT TCR===

		+	{{ABSTRACT_PUBMED_22820602}}

	==About this Structure==		==About this Structure==

OCA at 07:20, 25 July 2012

OCA — Wed, 25 Jul 2012 07:20:00 GMT

←Older revision		Revision as of 07:20, 25 July 2012
Line 1:		Line 1:
-	~~'''Unreleased structure'''~~	+	[[Image:4elk.jpg\|left\|200px]]

-	~~The entry~~ 4elk ~~is ON HOLD~~ ~~until Paper Publication~~	+	{{STRUCTURE_4elk\| PDB=4elk \| SCENE= }}

-	~~Authors: Girardi, E., Maricic, I., Wang, J., Mac, T.T., Iyer, P., Kumar, V., Zajonc, D.M~~.	+	===Crystal structure of the Hy19.3 type II NKT TCR===

-	~~Description: Crystal~~ structure ~~of the Hy19~~.~~3 type II NKT TCR~~	+
		+	==About this Structure==
		+	[[4elk]] is a 4 chain structure with sequence from [http://en.wikipedia.org/wiki/Mus_musculus Mus musculus]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=4ELK OCA].
		+	[[Category: Mus musculus]]
		+	[[Category: Girardi, E.]]
		+	[[Category: Iyer, P.]]
		+	[[Category: Kumar, V.]]
		+	[[Category: Mac, T T.]]
		+	[[Category: Maricic, I.]]
		+	[[Category: Wang, J.]]
		+	[[Category: Zajonc, D M.]]
		+	[[Category: Antigen presentation]]
		+	[[Category: Immune system]]
		+	[[Category: Type ii nkt cell]]

OCA at 05:37, 23 May 2012

OCA — Wed, 23 May 2012 05:37:40 GMT

←Older revision		Revision as of 05:37, 23 May 2012
Line 1:		Line 1:
	'''Unreleased structure'''		'''Unreleased structure'''

-	The entry 4elk is ON HOLD	+	The entry 4elk is ON HOLD until Paper Publication

	Authors: Girardi, E., Maricic, I., Wang, J., Mac, T.T., Iyer, P., Kumar, V., Zajonc, D.M.		Authors: Girardi, E., Maricic, I., Wang, J., Mac, T.T., Iyer, P., Kumar, V., Zajonc, D.M.

	Description: Crystal structure of the Hy19.3 type II NKT TCR		Description: Crystal structure of the Hy19.3 type II NKT TCR

OCA: Protected "4elk" [edit=sysop:move=sysop]

OCA — Wed, 18 Apr 2012 07:34:46 GMT

Protected "4elk" [edit=sysop:move=sysop]

←Older revision

Revision as of 07:34, 18 April 2012

OCA: New page: '''Unreleased structure''' The entry 4elk is ON HOLD Authors: Girardi, E., Maricic, I., Wang, J., Mac, T.T., Iyer, P., Kumar, V., Zajonc, D.M. Description: Crystal structure of the Hy1...

OCA — Wed, 18 Apr 2012 07:34:45 GMT

New page: '''Unreleased structure''' The entry 4elk is ON HOLD Authors: Girardi, E., Maricic, I., Wang, J., Mac, T.T., Iyer, P., Kumar, V., Zajonc, D.M. Description: Crystal structure of the Hy1...

New page

'''Unreleased structure'''

The entry 4elk is ON HOLD

Authors: Girardi, E., Maricic, I., Wang, J., Mac, T.T., Iyer, P., Kumar, V., Zajonc, D.M.

Description: Crystal structure of the Hy19.3 type II NKT TCR